Immune-modified Glasgow prognostic score: A new prognostic marker for head and neck cancer.
Kosuke TerazawaToshimitsu OhashiHirofumi ShibataTakuma IshiharaTakenori OgawaPublished in: Head & neck (2022)
imGPS is a more accurate predictor of clinical outcome in patients with HNSCC than mGPS.
Keyphrases